For years, statins have been widely prescribed to lower cholesterol and reduce the risk of cardiovascular events. They remain among the most commonly used medications worldwide, particularly for individuals at risk of heart attack or stroke. However, a growing body of research is prompting renewed discussion about their long-term effects, particularly in relation to coronary artery calcification and heart function.
An expert review published in Clinical Pharmacology has raised concerns that extended statin use may contribute to unintended consequences within the cardiovascular system. Specifically, the authors suggest that while statins effectively lower LDL cholesterol, they may also influence biological pathways that affect mitochondrial function, nutrient balance, and arterial calcification.
Mitochondrial Function and CoQ10 Depletion
One of the central concerns highlighted in the review involves coenzyme Q10 (CoQ10), a compound naturally produced in the body and essential for cellular energy production. CoQ10 plays a critical role in generating adenosine triphosphate (ATP), the molecule responsible for delivering energy within cells. This process is particularly vital in heart muscle cells, which require constant energy to sustain contraction and circulation.
Multiple studies have documented that statins inhibit the same biochemical pathway responsible for cholesterol synthesis, a pathway that also produces CoQ10. As a result, some researchers argue that prolonged statin therapy may reduce CoQ10 levels, potentially affecting mitochondrial efficiency.
The review described statins as possible “mitochondrial toxins” in certain contexts, suggesting that sustained CoQ10 depletion may impair energy production in heart muscle and vascular tissue. A 2022 study published in Biophysical Journal linked reduced ATP availability to heart failure progression, reinforcing the importance of mitochondrial energy balance.
Earlier research in BioFactors examined 50 statin users experiencing side effects such as fatigue and muscle discomfort. Participants discontinued statin therapy and supplemented with CoQ10 over an extended period. Many showed improvement or stabilization in cardiac function. The researchers concluded that some adverse effects attributed to statins may be reversible under certain circumstances, particularly when CoQ10 levels are restored.
Vitamin K and Arterial Calcification
Another area of concern centers on vitamin K, particularly vitamin K2, which plays a role in regulating calcium distribution in the body. Vitamin K2 activates proteins that help direct calcium into bones while preventing accumulation within blood vessel walls.
Coronary artery calcification occurs when calcium deposits form in the arteries that supply blood to the heart. This process is considered an early marker of coronary artery disease and can increase the risk of heart attack if plaque buildup progresses.
According to the expert review, statins may interfere with vitamin K–dependent pathways involved in managing calcification. A 2021 study published in the Kaohsiung Journal of Medical Sciences identified an association between statin use, vitamin K2 deficiency, and increased coronary artery calcification. The authors noted that their findings aligned with existing evidence suggesting a link between statins and vascular calcification.
However, the relationship remains complex. Some researchers argue that increased calcification observed in statin users may represent plaque stabilization rather than harm. Calcified plaques are sometimes considered more stable and less prone to rupture compared to soft plaques. Nonetheless, the review emphasizes the need for deeper investigation into how statins influence calcium metabolism over long durations.
Selenium and Selenoproteins
The review also addressed potential effects on selenoproteins, which depend on the trace mineral selenium. Selenium supports antioxidant defense systems and contributes to cardiovascular protection. Statins may influence the synthesis of certain selenoproteins, raising questions about whether prolonged therapy could impact oxidative balance within heart tissue.
While evidence in this area is still developing, researchers stress that nutrient interactions deserve careful study, particularly in patients taking statins for decades.
Debate Over Inflammation and Calcification
A 2022 study published in Arteriosclerosis, Thrombosis, and Vascular Biology reported increased arterial calcification among statin users. The authors proposed that inflammation may play a mediating role, rather than nutrient depletion alone.
This highlights the ongoing debate within cardiology: are statins contributing to calcification in a harmful way, or are they altering plaque composition in a protective manner? Some cardiologists argue that statins reduce overall cardiovascular risk despite changes in calcification scores. Others contend that long-term metabolic effects require closer scrutiny.
Clinical Awareness and Informed Consent
The review’s authors suggest that physicians may not always consider statins as a potential contributor when evaluating heart failure or cardiac dysfunction in long-term users. Instead, such conditions are often attributed to age, hypertension, or existing coronary artery disease.
With more than one million heart failure hospitalizations annually in the United States, the condition remains a major public health concern. The researchers argue that clinicians should provide comprehensive information regarding potential side effects, including emerging discussions about mitochondrial function, nutrient depletion, and calcification pathways.
They emphasize the ethical importance of informed consent, particularly when medications are prescribed for preventive purposes over extended periods. Patients, they argue, should be aware of both established benefits and areas of ongoing scientific debate.
The evolving research does not negate the substantial evidence supporting statins in reducing cardiovascular events among high-risk individuals. Instead, it underscores the need for individualized assessment, continuous monitoring, and further long-term studies exploring the balance between cholesterol reduction and broader metabolic effects.
